Clinical Trials Logo

Clinical Trial Summary

This study is a longer-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia


Clinical Trial Description

This clinical trial is designed to assess the long-term safety and activity of intra-parotid administration of AAV2hAQP1 in subjects with radiation-induced parotid salivary hypofunction and xerostomia. After completion of their Month 12 Follow-Up visit in Study MGT016, subjects will be invited to enroll in this 4 year follow-up study during which they will be assessed for up to 60 months following study drug administration. This follow-up trial is a non-interventional study designed to collect data on longer-term safety and activity at 24, 36, 48, and 60 months following study drug administration (for a total of 4 visits). Over the course of the study, subjects will undergo physical and oral examinations; vital sign measurements; weight measurements; AE assessments; concurrent medication assessments; sample blood collection for hematology and chemistry; urinalysis; 12-lead ECGs; ear, nose, and throat (ENT) screening for malignancy; imaging assessments (if indicated); salivary flow assessments; and questionnaire assessments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05060341
Study type Observational
Source MeiraGTx UK II Ltd
Contact
Status Enrolling by invitation
Phase
Start date November 12, 2020
Completion date November 2027

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02589938 - Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer N/A
Terminated NCT00682747 - Hyperbaric Oxygen for the Treatment of a Dry Mouth Which Occurred After Radiotherapy Phase 2
Completed NCT03035825 - Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients N/A
Completed NCT01885065 - Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients N/A
Completed NCT01195233 - Comparative Analysis of BioXtra on Xerostomia Phase 2
Completed NCT05020067 - Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy Phase 2